ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: We have recently established the first aging mouse model of CML at 18 months of age [34], enabling us to examine the effects of sex on BCR-ABL1 transformation and CML progression in a context more reflective of elderly humans.